C4A explained

Complement C4-A is a kind of the Complement component 4 protein that in humans is encoded by the C4A gene.[1]

Function

This gene encodes the acidic form of complement factor 4, part of the classical activation pathway. The protein is expressed as a single chain precursor which is proteolytically cleaved into a trimer of alpha, beta, and gamma chains prior to secretion. The trimer provides a surface for interaction between the antigen-antibody complex and other complement components. The alpha chain may be cleaved to release C4 anaphylatoxin, a mediator of local inflammation. Deficiency of this protein is associated with systemic lupus erythematosus and type I diabetes mellitus.[2] [3] [4] [5] [6] [7] Excess production due to a copy number that is higher than normal has shown a high probability of a causal relationship with schizophrenia and bipolar disorder with psychosis, which could explain the hereditary nature of these illnesses.[8] This gene localizes to the RCCX locus within the major histocompatibility complex (MHC) class III region on chromosome 6.[9] [10] Varying haplotypes of this gene cluster exist, such that individuals may have 1, 2, or 3 copies of this gene. Each copy of the gene, due to five adjacent nucleotide substitutions cause four amino acid changes and immunological subfunctionalization,[11] can be of one of two types: C4A and C4B.[12] Each gene contains 41 exons and has a dichotomous size variation between approximately 22 kb and 16 kb, with the longer variant being the result of the integration of the endogenous retrovirus HERV-K(C4) into intron 9.[10]

See also

Further reading

Notes and References

  1. Web site: Entrez Gene: C4A complement component 4A (Rodgers blood group).
  2. Dawkins RL, Uko G, Christiansen FT, Kay PH . Low C4 concentrations in insulin dependent diabetes mellitus . British Medical Journal . 287 . 6395 . 839 . Sep 1983 . 6412852 . 1549128 . 10.1136/bmj.287.6395.839-b .
  3. Vergani D, Johnston C, B-Abdullah N, Barnett AH . Low serum C4 concentrations: an inherited predisposition to insulin dependent diabetes? . British Medical Journal . 286 . 6369 . 926–8 . Mar 1983 . 6403137 . 1547358 . 10.1136/bmj.286.6369.926 .
  4. Mijovic CH, Fletcher JA, Bradwell AR, Barnett AH . Low C4 levels in type 1 (insulin-dependent) diabetes . Diabetologia . 30 . 10 . 824 . Oct 1987 . 3428499 . 10.1007/bf00275752 . free .
  5. Thomsen M, Mølvig J, Zerbib A, de Preval C, Abbal M, Dugoujon JM, Ohayon E, Svejgaard A, Cambon-Thomsen A, Nerup J . The susceptibility to insulin-dependent diabetes mellitus is associated with C4 allotypes independently of the association with HLA-DQ alleles in HLA-DR3,4 heterozygotes . Immunogenetics . 28 . 5 . 320–7 . 1988 . 3139557 . 10.1007/BF00364230 . 6521141 .
  6. Jenhani F, Bardi R, Gorgi Y, Ayed K, Jeddi M . C4 polymorphism in multiplex families with insulin dependent diabetes in the Tunisian population: standard C4 typing methods and RFLP analysis . Journal of Autoimmunity . 5 . 2 . 149–60 . Apr 1992 . 1352685 . 10.1016/0896-8411(92)90196-w .
  7. Lhotta K, Auinger M, Kronenberg F, Irsigler K, König P. Polymorphism of complement C4 and susceptibility to IDDM and microvascular complications. Diabetes Care. 1996. 19. 1. 53–55. 10.2337/diacare.19.1.53. 8720534. 8999525.
  8. Melbourne JK, Rosen C, Feiner B, Sharma RP . C4A mRNA expression in PBMCs predicts the presence and severity of delusions in schizophrenia and bipolar disorder with psychosis . Schizophrenia Research . 197 . 321–327 . July 2018 . 29449061 . 6087677 . 10.1016/j.schres.2018.01.018 .
  9. Zhou D, Rudnicki M, Chua GT, Lawrance SK, Zhou B, Drew JL, Barbar-Smiley F, Armstrong TK, Hilt ME, Birmingham DJ, Passler W, Auletta JJ, Bowden SA, Hoffman RP, Wu YL, Jarjour WN, Mok CC, Ardoin SP, Lau YL, Yu CY . Human Complement C4B Allotypes and Deficiencies in Selected Cases With Autoimmune Diseases . Front Immunol . 12 . 739430 . 2021 . 34764957 . 8577214 . 10.3389/fimmu.2021.739430 . free .
  10. Carrozza C, Foca L, De Paolis E, Concolino P . Genes and Pseudogenes: Complexity of the RCCX Locus and Disease . Front Endocrinol (Lausanne) . 12 . 709758 . 2021 . 34394006 . 8362596 . 10.3389/fendo.2021.709758 . free .
  11. Bánlaki Z, Szabó JA, Szilágyi Á, Patócs A, Prohászka Z, Füst G, Doleschall M . Intraspecific evolution of human RCCX copy number variation traced by haplotypes of the CYP21A2 gene . Genome Biol Evol . 5 . 1 . 98–112 . 2013 . 23241443 . 3595039 . 10.1093/gbe/evs121 .
  12. Doleschall M, Luczay A, Koncz K, Hadzsiev K, Erhardt É, Szilágyi Á, Doleschall Z, Németh K, Török D, Prohászka Z, Gereben B, Fekete G, Gláz E, Igaz P, Korbonits M, Tóth M, Rácz K, Patócs A . A unique haplotype of RCCX copy number variation: from the clinics of congenital adrenal hyperplasia to evolutionary genetics . Eur J Hum Genet . 25 . 6 . 702–710 . June 2017 . 28401898 . 5477366 . 10.1038/ejhg.2017.38 .